Moderna Secures $1.5B Loan for Growth
Update: 2025-11-20
Description
Moderna Secures $1.5B Loan for Future Growth: Despite a drop in COVID vaccine sales, the company aims for 10% revenue growth next year, drawing $600M upfront from Ares Management. They plan to fund new business developments and invest in promising opportunities, including new mRNA vaccines and partnerships in the UK, Canada, and Australia. Moderna expects between $1.6B and $2B in sales for 2025 and aims to break even by 2028, with increased investments in cancer and rare disease R&D.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
